Thiazolopyrimidine modulators as immunosuppressive agents

The present invention relates to compound of formula I, II, III, or IV, and/or a pharmaceutical acceptable addition salt thereof and/or a stereoisomer thereof and/or a solvate thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R11, and R12 are as defined in the claim 1. The present invention also...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JANG MI-YEON, WAER MARK JOZEF ALBERT, LOUAT THIERRY ANDRE MICHEL, VANDERHOYDONCK BART, GAO LING-JIE, LIN YUAN, HERMAN JEAN FERDINAND, HERDEWIJN PIET, DE JONGHE STEVEN
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator JANG MI-YEON
WAER MARK JOZEF ALBERT
LOUAT THIERRY ANDRE MICHEL
VANDERHOYDONCK BART
GAO LING-JIE
LIN YUAN
HERMAN JEAN FERDINAND
HERDEWIJN PIET
DE JONGHE STEVEN
description The present invention relates to compound of formula I, II, III, or IV, and/or a pharmaceutical acceptable addition salt thereof and/or a stereoisomer thereof and/or a solvate thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R11, and R12 are as defined in the claim 1. The present invention also relates to a method for their preparation, as well as to pharmaceutical compositions thereof. The present invention further relates to the use of said compounds as biologically active ingredients, more specifically as medicaments for the treatment of disorders and pathologic conditions such as, but not limited to, immune and auto-immune disorders, organ and cells transplant rejections.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US8901132B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US8901132B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US8901132B23</originalsourceid><addsrcrecordid>eNrjZLAMychMrMrPyS-oLMrMzUzJzEtVyM1PKc1JLMkvKlZILFbIzM0tzcsvLi0oKEotLs4sS1VITE_NKynmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxocEWlgaGhsZGTkbGRCgBAJcLL-Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Thiazolopyrimidine modulators as immunosuppressive agents</title><source>esp@cenet</source><creator>JANG MI-YEON ; WAER MARK JOZEF ALBERT ; LOUAT THIERRY ANDRE MICHEL ; VANDERHOYDONCK BART ; GAO LING-JIE ; LIN YUAN ; HERMAN JEAN FERDINAND ; HERDEWIJN PIET ; DE JONGHE STEVEN</creator><creatorcontrib>JANG MI-YEON ; WAER MARK JOZEF ALBERT ; LOUAT THIERRY ANDRE MICHEL ; VANDERHOYDONCK BART ; GAO LING-JIE ; LIN YUAN ; HERMAN JEAN FERDINAND ; HERDEWIJN PIET ; DE JONGHE STEVEN</creatorcontrib><description>The present invention relates to compound of formula I, II, III, or IV, and/or a pharmaceutical acceptable addition salt thereof and/or a stereoisomer thereof and/or a solvate thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R11, and R12 are as defined in the claim 1. The present invention also relates to a method for their preparation, as well as to pharmaceutical compositions thereof. The present invention further relates to the use of said compounds as biologically active ingredients, more specifically as medicaments for the treatment of disorders and pathologic conditions such as, but not limited to, immune and auto-immune disorders, organ and cells transplant rejections.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20141202&amp;DB=EPODOC&amp;CC=US&amp;NR=8901132B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25547,76298</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20141202&amp;DB=EPODOC&amp;CC=US&amp;NR=8901132B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JANG MI-YEON</creatorcontrib><creatorcontrib>WAER MARK JOZEF ALBERT</creatorcontrib><creatorcontrib>LOUAT THIERRY ANDRE MICHEL</creatorcontrib><creatorcontrib>VANDERHOYDONCK BART</creatorcontrib><creatorcontrib>GAO LING-JIE</creatorcontrib><creatorcontrib>LIN YUAN</creatorcontrib><creatorcontrib>HERMAN JEAN FERDINAND</creatorcontrib><creatorcontrib>HERDEWIJN PIET</creatorcontrib><creatorcontrib>DE JONGHE STEVEN</creatorcontrib><title>Thiazolopyrimidine modulators as immunosuppressive agents</title><description>The present invention relates to compound of formula I, II, III, or IV, and/or a pharmaceutical acceptable addition salt thereof and/or a stereoisomer thereof and/or a solvate thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R11, and R12 are as defined in the claim 1. The present invention also relates to a method for their preparation, as well as to pharmaceutical compositions thereof. The present invention further relates to the use of said compounds as biologically active ingredients, more specifically as medicaments for the treatment of disorders and pathologic conditions such as, but not limited to, immune and auto-immune disorders, organ and cells transplant rejections.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAMychMrMrPyS-oLMrMzUzJzEtVyM1PKc1JLMkvKlZILFbIzM0tzcsvLi0oKEotLs4sS1VITE_NKynmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxocEWlgaGhsZGTkbGRCgBAJcLL-Q</recordid><startdate>20141202</startdate><enddate>20141202</enddate><creator>JANG MI-YEON</creator><creator>WAER MARK JOZEF ALBERT</creator><creator>LOUAT THIERRY ANDRE MICHEL</creator><creator>VANDERHOYDONCK BART</creator><creator>GAO LING-JIE</creator><creator>LIN YUAN</creator><creator>HERMAN JEAN FERDINAND</creator><creator>HERDEWIJN PIET</creator><creator>DE JONGHE STEVEN</creator><scope>EVB</scope></search><sort><creationdate>20141202</creationdate><title>Thiazolopyrimidine modulators as immunosuppressive agents</title><author>JANG MI-YEON ; WAER MARK JOZEF ALBERT ; LOUAT THIERRY ANDRE MICHEL ; VANDERHOYDONCK BART ; GAO LING-JIE ; LIN YUAN ; HERMAN JEAN FERDINAND ; HERDEWIJN PIET ; DE JONGHE STEVEN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US8901132B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2014</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>JANG MI-YEON</creatorcontrib><creatorcontrib>WAER MARK JOZEF ALBERT</creatorcontrib><creatorcontrib>LOUAT THIERRY ANDRE MICHEL</creatorcontrib><creatorcontrib>VANDERHOYDONCK BART</creatorcontrib><creatorcontrib>GAO LING-JIE</creatorcontrib><creatorcontrib>LIN YUAN</creatorcontrib><creatorcontrib>HERMAN JEAN FERDINAND</creatorcontrib><creatorcontrib>HERDEWIJN PIET</creatorcontrib><creatorcontrib>DE JONGHE STEVEN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JANG MI-YEON</au><au>WAER MARK JOZEF ALBERT</au><au>LOUAT THIERRY ANDRE MICHEL</au><au>VANDERHOYDONCK BART</au><au>GAO LING-JIE</au><au>LIN YUAN</au><au>HERMAN JEAN FERDINAND</au><au>HERDEWIJN PIET</au><au>DE JONGHE STEVEN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Thiazolopyrimidine modulators as immunosuppressive agents</title><date>2014-12-02</date><risdate>2014</risdate><abstract>The present invention relates to compound of formula I, II, III, or IV, and/or a pharmaceutical acceptable addition salt thereof and/or a stereoisomer thereof and/or a solvate thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R11, and R12 are as defined in the claim 1. The present invention also relates to a method for their preparation, as well as to pharmaceutical compositions thereof. The present invention further relates to the use of said compounds as biologically active ingredients, more specifically as medicaments for the treatment of disorders and pathologic conditions such as, but not limited to, immune and auto-immune disorders, organ and cells transplant rejections.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US8901132B2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Thiazolopyrimidine modulators as immunosuppressive agents
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T20%3A46%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JANG%20MI-YEON&rft.date=2014-12-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS8901132B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true